The Influence of Prescribed Exercise on Pain Related Fear Following Concussion in Collegiate Athletes: A Randomized Controlled Trial

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this clinical trial is to compare the effects of acute aerobic exercise at two different intensities on psychological measures, symptomology, and time to symptom free in collegiate student athletes with concussion. The main questions it aims to answer are: * Does prescribed, acute aerobic exercise influence measures of pain related fear, anxiety, depression, symptoms, and recovery time? * Does the intensity of the exercise prescription also influence the aforementioned outcomes? Participants will be randomly assigned into either a light intensity or moderate intensity aerobic exercise (treadmill walking) group. They will initiate the exercise protocol 48 hours following their concussion diagnosis, and complete exercise sessions 5 times per week until they report symptom-free. Researchers will compare the light intensity group to the moderate intensity group to see if intensity of exercise influences psychological measures of pain related fear, anxiety, depression, symptomology, and time to symptom-free.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 25
Healthy Volunteers: f
View:

• Collegiate athlete (varsity)

• Symptomatic at time of exercise prescription

Locations
United States
Virginia
University of Virginia Department of Kinesiology
RECRUITING
Charlottesville
Contact Information
Primary
Jake Resch, PhD
jer6x@virginia.edu
434-243-6535
Backup
Daniel Rosenblum, M.Ed.
dr6gz@virginia.edu
203-253-4887
Time Frame
Start Date: 2024-02-27
Estimated Completion Date: 2025-03
Participants
Target number of participants: 46
Treatments
Experimental: Moderate Intensity
Treadmill walking at a rating of perceived exertion (RPE) of 13.
Experimental: Light Intensity
Treadmill walking at a rating of perceived exertion (RPE) of 9.
Related Therapeutic Areas
Sponsors
Leads: University of Virginia

This content was sourced from clinicaltrials.gov